Lista de obras -

A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase

artículo científico publicado en 2014

Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice.

artículo científico publicado en 2008

An Extrahepatic Receptor-associated Protein-sensitive Mechanism Is Involved in the Metabolism of Triglyceride-rich Lipoproteins

artículo científico publicado en 1999

An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1.

artículo científico publicado en 2016

Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes

artículo científico publicado en 2016

Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells.

artículo científico publicado en 2012

Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase

artículo científico publicado en 2011

Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells

artículo científico publicado en 2010

Biography of Donald Berthold Zilversmit1 ⬇️

artículo científico publicado el 21 de diciembre de 2011

Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression

artículo científico publicado en 2004

Cholesterol intake modulates plasma triglyceride levels in glycosylphosphatidylinositol HDL-binding protein 1-deficient mice

artículo científico publicado en 2010

Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1

artículo científico publicado en 2012

Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase

artículo científico publicado en 2009

Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects

artículo científico publicado en 2010

Deletion of GPIHBP1 causing severe chylomicronemia ⬇️

artículo científico publicado el 19 de octubre de 2011

Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus

artículo científico publicado en 2005

Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter

artículo científico publicado en 2014

GPIHBP1 and Plasma Triglyceride Metabolism

artículo científico publicado en 2016

GPIHBP1 and lipolysis: an update

artículo científico publicado en 2009

GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries

artículo científico publicado en 2010

GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.

artículo científico publicado en 2014

GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins

artículo científico publicado en 2008

GPIHBP1, an endothelial cell transporter for lipoprotein lipase ⬇️

artículo científico publicado el 15 de agosto de 2011

GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons

artículo científico publicado en 2007

Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase

artículo científico publicado en 2008

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons

artículo científico publicado en 2007

Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol

artículo científico publicado en 2004

Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase.

artículo científico publicado en 2009

Identification of mouse and human macrophages as a site of synthesis of hepatic lipase.

artículo científico publicado en 2002

In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation

artículo científico publicado en 2008

Interaction of lipoprotein lipase and receptor-associated protein

scientific journal article

Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy

artículo científico publicado en 2003

Lipoprotein lipase reaches the capillary lumen in chickens despite an apparent absence of GPIHBP1.

artículo científico publicado en 2017

Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models

artículo científico publicado en 2008

Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members

artículo científico publicado en 2007

Localization of lipoprotein lipase and GPIHBP1 in mouse pancreas: effects of diet and leptin deficiency

artículo científico publicado en 2012

Mice expressing only covalent dimeric heparin binding-deficient lipoprotein lipase: muscles inefficiently secrete dimeric enzyme

artículo científico publicado en 2003

Mobility of "HSPG-bound" LPL explains how LPL is able to reach GPIHBP1 on capillaries

artículo científico publicado en 2016

Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain

artículo científico publicado en 2014

Murine glypican-4 gene structure and expression; Sp1 and Sp3 play a major role in glypican-4 expression in 3T3-F442A cells

artículo científico publicado en 2004

Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1

artículo científico publicado en 2011

Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution

artículo científico publicado en 2007

Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase

artículo científico publicado en 2002

Sandwich immunoassay for the measurement of murine syndecan-4.

artículo científico publicado en 2002

Stabilizing lipoprotein lipase

artículo científico publicado en 2009

The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolism

scientific journal article

The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries

artículo científico publicado en 2014

The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons

artículo científico publicado en 2008

Transgenic expression and genetic variation of Lmf1 affect LPL activity in mice and humans

artículo científico publicado en 2012

Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice

artículo científico publicado en 2005

Lista de obras de

A new monoclonal antibody, 4-1a, that binds to the amino terminus of human lipoprotein lipase

Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice.

An Extrahepatic Receptor-associated Protein-sensitive Mechanism Is Involved in the Metabolism of Triglyceride-rich Lipoproteins

An LPL-specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1.

Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes

Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells.

Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase

Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells

Biography of Donald Berthold Zilversmit1 ⬇️

Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression

Cholesterol intake modulates plasma triglyceride levels in glycosylphosphatidylinositol HDL-binding protein 1-deficient mice

Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1

Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase

Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects

Deletion of GPIHBP1 causing severe chylomicronemia ⬇️

Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus

Equivalent binding of wild-type lipoprotein lipase (LPL) and S447X-LPL to GPIHBP1, the endothelial cell LPL transporter

GPIHBP1 and Plasma Triglyceride Metabolism

GPIHBP1 and lipolysis: an update

GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries

GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.

GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins

GPIHBP1, an endothelial cell transporter for lipoprotein lipase ⬇️

GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons

Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons

Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol

Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase.

Identification of mouse and human macrophages as a site of synthesis of hepatic lipase.

In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation

Interaction of lipoprotein lipase and receptor-associated protein

Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy

Lipoprotein lipase reaches the capillary lumen in chickens despite an apparent absence of GPIHBP1.

Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models

Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members

Localization of lipoprotein lipase and GPIHBP1 in mouse pancreas: effects of diet and leptin deficiency

Mice expressing only covalent dimeric heparin binding-deficient lipoprotein lipase: muscles inefficiently secrete dimeric enzyme

Mobility of "HSPG-bound" LPL explains how LPL is able to reach GPIHBP1 on capillaries

Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain

Murine glypican-4 gene structure and expression; Sp1 and Sp3 play a major role in glypican-4 expression in 3T3-F442A cells

Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1

Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution

Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase

Sandwich immunoassay for the measurement of murine syndecan-4.

Stabilizing lipoprotein lipase

The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolism

The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries

The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons

Transgenic expression and genetic variation of Lmf1 affect LPL activity in mice and humans

Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice